Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2026-02-20 @ 10:45 PM
Study NCT ID:
NCT00981058
Status:
COMPLETED
Last Update Posted:
2025-06-18
First Post:
2009-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01-07
Start Date Type:
ACTUAL
Primary Completion Date:
2013-06-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-18
First Submit QC Date:
None
Study First Post Date:
2009-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-21
Results First Submit QC Date:
None
Results First Post Date:
2016-06-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-09-09
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2025-05-30
Last Update Post Date:
2025-06-18
Last Update Post Date Type:
ACTUAL